E Kenneth Weir
Overview
Explore the profile of E Kenneth Weir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
3556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerges C, Vollmers K, Skoro-Sajer N, Dannenberg V, Hartig V, Pritzker M, et al.
Eur J Heart Fail
. 2024 Mar;
26(3):686-694.
PMID: 38481353
Aims: A common feature of various forms of pulmonary hypertension (PH) is progressive decline of pulmonary arterial compliance (C), which correlates with reduced survival. In this acute study, we evaluated...
2.
Moutsoglou D, Tatah J, Prisco S, Prins K, Staley C, Lopez S, et al.
Am J Respir Crit Care Med
. 2022 Nov;
207(6):740-756.
PMID: 36343281
Inflammation drives pulmonary arterial hypertension (PAH). Gut dysbiosis causes immune dysregulation and systemic inflammation by altering circulating microbial metabolites; however, little is known about gut dysbiosis and microbial metabolites in...
3.
Prisco S, Eklund M, Moutsoglou D, Prisco A, Khoruts A, Weir E, et al.
J Am Heart Assoc
. 2021 Nov;
10(22):e022722.
PMID: 34747187
Background Intermittent fasting (IF) confers pleiotropic cardiovascular benefits including restructuring of the gut microbiome and augmentation of cellular metabolism. Pulmonary arterial hypertension (PAH) is a rare and lethal disease characterized...
4.
Sharma N, Nagaraj C, Nagy B, Marsh L, Bordag N, Zabini D, et al.
Int J Mol Sci
. 2021 Sep;
22(17).
PMID: 34502263
The regulator of G protein signaling (RGS) represents a widespread system of controllers of cellular responses. The activities of the R4 subfamily of RGSs have been elucidated in allergic pulmonary...
5.
Thenappan T, Weir E, Prins K, Pritzker M, Archer S
J Am Heart Assoc
. 2021 Jul;
10(14):e021518.
PMID: 34259020
No abstract available.
6.
Vijayaraghavan M, Prins K, Prisco S, Duval S, John R, Archer S, et al.
CJC Open
. 2021 May;
3(4):488-497.
PMID: 34027352
Background: The impact of pulmonary hypertension (PH) on outcomes after surgical tricuspid valve replacement (TVR) and repair (TVr) is unclear. We sought to characterize PH in patients undergoing TVR/TVr, based...
7.
Tatah J, Weir E, Prins K, Thenappan T
Chest
. 2021 May;
159(4):e193-e196.
PMID: 34022017
We report here a case of portopulmonary hypertension following transjugular intrahepatic portosystemic shunt.
8.
Gerges C, Vollmers K, Pritzker M, Gainor J, Scandurra J, Weir E, et al.
J Am Coll Cardiol
. 2020 Nov;
76(19):2284-2286.
PMID: 33153589
No abstract available.
9.
Thenappan T, Weir E
Am J Respir Crit Care Med
. 2020 Jul;
202(7):928-929.
PMID: 32640166
No abstract available.
10.
Weir E, Thenappan T, Bhargava M, Chen Y
Clin Med (Lond)
. 2020 Jun;
20(4):e107-e108.
PMID: 32503801
The severity of coronavirus 2019 infection (COVID-19) is determined by the presence of pneumonia, severe acute respiratory distress syndrome (SARS-CoV-2), myocarditis, microvascular thrombosis and/or cytokine storms, all of which involve...